Is Avalo Therapeutics, Inc. (AVTX) a Buy, Sell, or Hold?
NASDAQ : AVTX
Avalo Therapeutics, Inc. — Institutional Ownership
$18.5169 USD
-$0.32 (-1.71%)
- Volume
- 399.41K
- Average Volume
- 1.94M
- Market Capitalization
- $209.13M
- P/E Ratio
- -3.91
- Dividend Yield
- 0.00%
- Price Target
- $45.00
- Year High
- $24.27
- Year Low
- $8.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.31
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-27 | BlackRock, Inc. | 3.42M | 6.50% |
| 2026-07-06 | Millennium Management LLC | 9857.0 | 0.00% |
| 2026-06-18 | Commodore Capital LP | 5.72M | 9.90% |
| 2026-06-05 | FMR LLC | 3.19M | 6.10% |
| 2026-05-29 | Deep Track Capital, LP | 3.06M | 5.81% |
| 2026-05-26 | Point72 Asset Management, L.P. | 2.71M | 5.20% |
| 2026-05-15 | Caligan Partners LP | 1.64M | 7.20% |
| 2026-05-15 | BIOTECHNOLOGY VALUE FUND L P | 1.26M | 5.40% |
| 2026-05-15 | OrbiMed Advisors LLC | 475.16K | 2.10% |
| 2026-05-15 | Avoro Capital Advisors LLC | 1.41M | 5.75% |
| 2026-05-15 | RA Capital Management, L.P. | 2.46M | 9.90% |
| 2026-05-15 | Logos Global Management LP | 1.68M | 3.20% |
| 2026-05-15 | T. Rowe Price Investment Management, Inc. | 2.16M | 9.50% |
| 2026-05-14 | Affinity Asset Advisors, LLC | 1.34M | 5.50% |
| 2026-05-12 | TCG Crossover GP II, LLC | 3.02M | 7.90% |
| 2026-05-06 | FMR LLC | 2.88M | 12.60% |
| 2026-04-01 | Logos Global Management LP | 1.28M | 5.60% |
| 2026-03-06 | FMR LLC | 2.13M | 11.50% |
| 2026-02-24 | Millennium Management LLC | 934.43K | 5.00% |
| 2026-02-17 | Millennium Management LLC | 887.27K | 4.80% |
| 2026-02-17 | OrbiMed Advisors LLC | 1.19M | 6.40% |
| 2026-02-17 | RA Capital Management, L.P. | 1.94M | 9.90% |
| 2026-02-17 | BIOTECHNOLOGY VALUE FUND L P | 1.29M | 6.80% |
| 2026-02-17 | Point72 Asset Management, L.P. | 627.5K | 3.50% |
| 2026-02-17 | Balyasny Asset Management L.P. | 439.31K | 2.42% |
| 2026-02-17 | Caligan Partners LP | 881.53K | 4.90% |
| 2026-02-10 | SilverArc Capital Management, LLC | 524.44K | 2.83% |
| 2026-02-10 | Millennium Management LLC | 906.76K | 4.90% |
| 2026-02-03 | Millennium Management LLC | 905.8K | 4.90% |
| 2026-01-30 | The Vanguard Group | 804.08K | 4.43% |
| 2026-01-29 | Affinity Asset Advisors, LLC | 1.05M | 5.70% |
| 2025-11-14 | Point72 Asset Management, L.P. | 1.05M | 8.00% |
| 2025-11-14 | RA Capital Management, L.P. | 1.39M | 9.90% |
| 2025-11-14 | Nantahala Capital Management, LLC | 1.24M | 9.39% |
| 2025-11-14 | Deep Track Capital, LP | - | 0.00% |
| 2025-11-14 | Balyasny Asset Management L.P. | 817.44K | 6.22% |
| 2025-11-14 | SilverArc Capital Management, LLC | 720.92K | 5.48% |
| 2025-11-14 | Caligan Partners LP | 833.33K | 6.30% |
| 2025-11-14 | BIOTECHNOLOGY VALUE FUND L P | 806.41K | 5.50% |
| 2025-11-14 | Ikarian Capital, LLC | 711.97K | 3.80% |
| 2025-11-13 | Affinity Healthcare Fund, LP | 1.01M | 7.65% |
| 2025-10-30 | The Vanguard Group | 692.64K | 5.26% |
| 2025-08-27 | Patrick J. Crutcher | 549.47K | 4.20% |
| 2025-08-14 | OrbiMed Advisors LLC | 967K | 8.90% |
| 2025-08-05 | Point72 Asset Management, L.P. | 588.63K | 5.40% |
| 2025-05-15 | Ikarian Capital, LLC | 1.19M | 9.99% |
| 2025-05-15 | RA Capital Management, L.P. | 1.09M | 9.90% |
| 2025-05-15 | Nantahala Capital Management, LLC | 900K | 8.43% |
| 2025-02-14 | BIOTECHNOLOGY VALUE FUND L P | 550.55K | 5.30% |
| 2024-12-31 | Affinity Healthcare Fund, LP | 550.76K | 5.30% |
| 2024-11-14 | OrbiMed Advisors LLC | 967K | 9.90% |
| 2024-11-14 | OrbiMed Advisors LLC | 967K | 9.90% |
| 2024-11-14 | OrbiMed Capital GP IX LLC | 644.67K | 6.70% |
| 2024-11-14 | OrbiMed Capital GP IX LLC | 644.67K | 6.70% |
| 2024-10-07 | Ikarian Capital, LLC | 970.36K | 10.02% |
| 2024-10-07 | Neil Shahrestani | 970.36K | 10.02% |
| 2024-10-07 | Ikarian Capital, LLC | 970.36K | 10.02% |
| 2024-10-07 | Neil Shahrestani | 970.36K | 10.02% |
| 2024-08-23 | BVF II GP LLC | 403.12K | 4.20% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | Biotechnology Value Fund, L.P. | 512.35K | 5.30% |
| 2024-08-23 | BVF I GP LLC | 512.35K | 5.30% |
| 2024-08-23 | Biotechnology Value Fund II, L.P. | 403.12K | 4.20% |
| 2024-08-23 | BVF II GP LLC | 403.12K | 4.20% |
| 2024-08-23 | Biotechnology Value Fund, L.P. | 512.35K | 5.30% |
| 2024-08-23 | BVF Partners L.P. | 967.3K | 9.99% |
| 2024-08-23 | BVF Inc. | 967.3K | 9.99% |
| 2024-08-23 | Mark N. Lampert | 967.3K | 9.99% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | J. Crutcher | 110.85K | 9.90% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | BVF Partners L.P. | 967.3K | 9.99% |
| 2024-08-23 | BVF GP Holdings LLC | 915.47K | 9.50% |
| 2024-08-23 | BVF Inc. | 967.3K | 9.99% |
| 2024-08-23 | BVF I GP LLC | 512.35K | 5.30% |
| 2024-08-23 | Biotechnology Value Fund II, L.P. | 403.12K | 4.20% |
| 2024-08-23 | Biotechnology Value Trading Fund OS LP | 37791.0 | 1.00% |
| 2024-08-23 | BVF Partners OS Ltd. | 37791.0 | 1.00% |
| 2024-08-23 | BVF GP Holdings LLC | 915.47K | 9.50% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | J. Crutcher | 110.85K | 9.90% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | s | 967.3K | 9.99% |
| 2024-08-23 | Biotechnology Value Trading Fund OS LP | 37791.0 | 1.00% |
| 2024-08-23 | BVF Partners OS Ltd. | 37791.0 | 1.00% |
| 2024-08-23 | Mark N. Lampert | 967.3K | 9.99% |
| 2024-05-13 | David Modest | 78255.0 | 7.60% |
| 2024-05-13 | Christopher Staral | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Investments GP LLC | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Master Fund LP | 78255.0 | 7.60% |
| 2024-05-13 | David Modest | 78255.0 | 7.60% |
| 2024-05-13 | Christopher Staral | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Investments GP LLC | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Investments LP | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Master Fund LP | 78255.0 | 7.60% |
| 2024-05-13 | Allostery Investments LP | 78255.0 | 7.60% |
| 2024-04-23 | Emerald Bioventures, LLC | 58346.0 | 5.60% |
| 2024-04-23 | Timothy Opler | 58346.0 | 5.60% |
| 2024-04-23 | Timothy Opler | 58346.0 | 5.60% |
| 2024-04-23 | Emerald Bioventures, LLC | 58346.0 | 5.60% |
| 2024-04-05 | Deep Track Biotechnology Master Fund, Ltd. | 114.78K | 9.99% |
| 2024-04-05 | Deep Track Biotechnology Master Fund, Ltd. | 114.78K | 9.99% |
| 2024-04-05 | Deep Track Capital, LP | 114.78K | 9.99% |
| 2024-04-05 | David Kroin | 114.78K | 9.99% |
| 2024-04-05 | David Kroin | 114.78K | 9.99% |
| 2024-04-05 | Deep Track Capital, LP | 114.78K | 9.99% |
| 2023-02-17 | VHCP Co-Investment Holdings III, LLC | 1.35M | 9.99% |
| 2023-02-17 | Venrock Healthcare Capital Partners EG, L.P. | 1.35M | 9.99% |
| 2023-02-17 | VHCP Management III, LLC | 1.35M | 9.99% |
| 2023-02-17 | Shah, Nimish | 1.35M | 9.99% |
| 2023-02-17 | VHCP Co-Investment Holdings III, LLC | 1.35M | 9.99% |
| 2023-02-17 | VHCP Management III, LLC | 1.35M | 9.99% |
| 2023-02-17 | Venrock Healthcare Capital Partners EG, L.P. | 1.35M | 9.99% |
| 2023-02-17 | Venrock Healthcare Capital Partners III, L.P. | 1.35M | 9.99% |
| 2023-02-17 | VHCP Management EG, LLC | 1.35M | 9.99% |
| 2023-02-17 | Koh, Bong | 1.35M | 9.99% |
| 2023-02-17 | VHCP Management EG, LLC | 1.35M | 9.99% |
| 2023-02-17 | Shah, Nimish | 1.35M | 9.99% |
| 2023-02-17 | Koh, Bong | 1.35M | 9.99% |
| 2023-02-17 | Venrock Healthcare Capital Partners III, L.P. | 1.35M | 9.99% |
| 2023-02-13 | Great Point Partners, LLC | 974.64K | 7.12% |
| 2023-02-13 | Mr. Ortav Yehudai | 974.64K | 7.12% |
| 2023-02-13 | Mr. Ortav Yehudai | 974.64K | 7.12% |
| 2023-02-13 | Dr. Jeffrey R. Jay, M.D. | 974.64K | 7.12% |
| 2023-02-13 | Dr. Jeffrey R. Jay, M.D. | 974.64K | 7.12% |
| 2023-02-13 | Great Point Partners, LLC | 974.64K | 7.12% |
| 2022-08-08 | Cambyz Golestaneh | 980.56K | 10.43% |
| 2022-08-08 | Caissa Capital Management Ltd. | 798.26K | 8.49% |
| 2022-05-17 | Caissa Capital Management Ltd. | 4.1M | 3.63% |
| 2022-05-17 | Cambyz Golestaneh | 6.1M | 5.41% |
| 2022-02-14 | Nantahala Capital Management, LLC | 8.51M | 7.50% |
| 2022-02-14 | Nantahala Capital Management, LLC | 8.51M | 7.50% |
| 2022-02-14 | Point72 Hong Kong Limited | 3826.0 | 4.00% |
| 2022-02-14 | Wilmot B. Harkey | 8.51M | 7.50% |
| 2022-02-14 | Daniel Mack | 8.51M | 7.50% |
| 2022-02-14 | Steven A. Cohen | 6.01M | 4.00% |
| 2022-02-14 | Wilmot B. Harkey | 8.51M | 7.50% |
| 2022-02-14 | Point72 Asset Management, L.P. | 6.01M | 4.00% |
| 2022-02-14 | Point72 Capital Advisors, Inc. | 6.01M | 4.00% |
| 2022-02-14 | Daniel Mack | 8.51M | 7.50% |
| 2022-01-20 | Armistice Capital, LLC | 50.4M | 43.30% |
| 2022-01-20 | Steven Boyd | 50.81M | 43.70% |
| 2021-12-16 | Armistice Capital, LLC | 49M | 42.10% |
| 2021-12-16 | Steven Boyd | 49.41M | 42.50% |
| 2021-09-21 | Point72 Asset Management, L.P. | 6.01M | 4.00% |
| 2021-09-21 | Point72 Capital Advisors, Inc. | 6.01M | 4.00% |
| 2021-09-21 | Point72 Hong Kong Limited | 846.0 | 4.00% |
| 2021-09-21 | Steven A. Cohen | 6.01M | 4.00% |
| 2021-09-21 | Point72 Capital Advisors, Inc. | 6.01M | 4.00% |
| 2021-09-21 | Point72 Asset Management, L.P. | 6.01M | 4.00% |
| 2021-09-21 | Point72 Hong Kong Limited | 846.0 | 4.00% |
| 2021-09-21 | Steven A. Cohen | 6.01M | 4.00% |
| 2021-09-17 | Steven Boyd | 412.44K | 43.90% |
| 2021-09-17 | Armistice Capital, LLC | 49M | 43.60% |
| 2021-02-16 | Daniel Mack | 6.23M | 8.30% |
| 2021-02-16 | Wilmot B. Harkey | 6.23M | 8.30% |
| 2021-02-16 | Nantahala Capital Management, LLC | 6.23M | 8.30% |
| 2021-02-16 | Daniel Mack | 6.23M | 8.30% |
| 2021-02-16 | Wilmot B. Harkey | 6.23M | 8.30% |
| 2021-02-16 | Nantahala Capital Management, LLC | 6.23M | 8.30% |
| 2018-10-03 | ARK ASSET MANGEMENT CO., INC. | - | 0.00% |
| 2018-10-03 | Opaleye Management Inc. | 9.0 | 11.00% |
| 2018-10-03 | 1 | 9.0 | 11.00% |
| 2018-10-03 | 1 | 9.0 | 11.00% |
| 2018-02-12 | Sharyar Baradaran | 809.31K | 2.59% |
| 2016-02-12 | Apple Tree Partners IV, L.P. | 595.44K | 6.90% |
| 2016-02-12 | ATP III GP, Ltd. | 595.44K | 6.90% |
| 2016-02-12 | Seth L. Harrison | 595.44K | 6.90% |
| 2016-02-01 | NEA 14 GP, LTD | 594.24K | 6.90% |
| 2016-02-01 | Krishna S. Kolluri | 594.24K | 6.90% |
| 2016-02-01 | Scott D. Sandell | 594.24K | 6.90% |
| 2016-02-01 | Forest Baskett | 594.24K | 6.90% |
| 2016-02-01 | Peter J. Barris | 594.24K | 6.90% |
| 2016-02-01 | NEA Partners 14, L.P. | 594.24K | 6.90% |
| 2016-02-01 | NEA 14 GP, LTD | 594.24K | 6.90% |
| 2016-02-01 | M. James Barrett | 594.24K | 6.90% |
| 2016-02-01 | Anthony A. Florence, Jr. | 594.24K | 6.90% |
| 2016-02-01 | David M. Mott | 594.24K | 6.90% |
| 2016-02-01 | Peter W. Sonsini | 594.24K | 6.90% |
| 2016-02-01 | Ravi Viswanathan | 594.24K | 6.90% |
| 2016-02-01 | Harry R. Weller | 594.24K | 6.90% |
| 2016-02-01 | New Enterprise Associates 14, L.P. | 594.24K | 6.90% |
| 2016-02-01 | Forest Baskett | 594.24K | 6.90% |
| 2016-02-01 | Peter J. Barris | 594.24K | 6.90% |
| 2016-02-01 | Patrick J. Kerins | 594.24K | 6.90% |
| 2016-02-01 | David M. Mott | 594.24K | 6.90% |
| 2016-02-01 | Scott D. Sandell | 594.24K | 6.90% |
| 2016-02-01 | Peter W. Sonsini | 594.24K | 6.90% |
| 2016-02-01 | Ravi Viswanathan | 594.24K | 6.90% |
| 2016-02-01 | Harry R. Weller | 594.24K | 6.90% |
| 2016-02-01 | Anthony A. Florence, Jr. | 594.24K | 6.90% |
| 2016-02-01 | Patrick J. Kerins | 594.24K | 6.90% |
| 2016-02-01 | Krishna S. Kolluri | 594.24K | 6.90% |
| 2016-02-01 | M. James Barrett | 594.24K | 6.90% |
| 2016-02-01 | New Enterprise Associates 14, L.P. | 594.24K | 6.90% |
| 2016-02-01 | NEA Partners 14, L.P. | 594.24K | 6.90% |
AVTX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $18.16 | 13.4M | $243.43M | $15.86M | $2.43M | $230M |
| 2024-12-31 | $7.43 | 8.13M | $60.39M | $134.55M | $568K | -$73.58M |
| 2023-12-31 | $9.10 | 277.73K | $2.53M | $7.42M | $537K | -$4.35M |
| 2022-12-31 | $1209.60 | 39202 | $47.42M | $13.17M | $19.95M | $54.19M |
| 2021-12-31 | $4896.00 | 36191 | $177.19M | $54.58M | $33.32M | $155.92M |
| 2020-12-31 | $7603.20 | 25511 | $193.97M | $18.92M | $426K | $175.47M |
| 2019-12-31 | $15523.20 | 19849 | $308.12M | $3.61M | $155.82K | $304.67M |
| 2018-12-31 | $9302.40 | 12074 | $112.32M | $10.65M | $15.38M | $117.05M |
| 2017-12-31 | $9216.00 | 6392 | $58.91M | $2.47M | -$ | $56.44M |
| 2016-12-31 | $2534.40 | 3066 | $7.77M | $5.13M | $2.35M | $5M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18.48 | 43.6M | $805.77M | $85.38M | -$ | $720.38M |
| 2026-03-31 | $14.93 | 20.11M | $300.2M | $24.99M | $2.33M | $277.54M |
| 2025-12-31 | $18.16 | 18.51M | $336.19M | $15.86M | $2.43M | $322.76M |
| 2025-09-30 | $12.71 | 14M | $177.95M | $26.96M | $555K | $151.54M |
| 2025-06-30 | $4.99 | 10.83M | $54.04M | $42.29M | $679K | $12.43M |
| 2025-03-31 | $8.01 | 10.51M | $84.22M | $125.05M | $801K | -$40.02M |
| 2024-12-31 | $7.43 | 10.47M | $77.81M | $134.55M | $568K | -$56.17M |
| 2024-09-30 | $9.50 | 5.55M | $52.69M | $81.86M | $550K | -$28.62M |
| 2024-06-30 | $12.61 | 1.03M | $13.04M | $93.43M | $548K | -$79.84M |
| 2024-03-31 | $17.90 | 859.38K | $15.38M | $110.18M | $545K | -$94.25M |
| 2023-12-31 | $9.10 | 801.75K | $7.3M | $7.42M | $537K | $417.89K |
| 2023-09-30 | $29.04 | 194.85K | $5.66M | $10.18M | $536K | -$3.99M |